David Rezendes

David Rezendes has over 19 years of experience in the clinical operations field. David began their career in 2002 as a Clinical Research Coordinator at Rhode Island Mood & Memory. David then worked as a Clinical Research Associate at ActivBiotics and EPIX Pharmaceuticals from 2007 to 2009. From 2009 to 2010, they worked as a Sr. Clinical Research Associate at Hologic, Inc. and Covidien. From 2011 to 2014, they worked at Johnson & Johnson - Codman Neuro as a Clinical Program Manager. David then worked at Alkermes from 2014 to 2019 in various roles, including Associate Director, Clinical Program Management, Clinical Program Manager, and Senior Clinical Trial Manager. Since 2019, they have been working at Apellis Pharmaceuticals as a Director Clinical Operations and Associate Director Clinical Operations. David is currently the Vice President Clinical Operations at Q32 Bio Inc.

David Rezendes obtained their Bachelor's degree from Johnson & Wales University in Marketing/Marketing Management, General in 2011. David then went on to receive their Master's degree from Drexel University in Clinical Research Management in 2013.